Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR2 | P30874 | 18/20 | 0.64 |
| ▸ | SSTR5 | P35346 | 17/20 | 0.64 |
| ▸ | SSTR4 | P31391 | 15/20 | 0.64 |
| ▸ | SSTR3 | P32745 | 13/20 | 0.63 |
| ▸ | SSTR1 | P30872 | 6/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21917396 | 0.86 | SSTR2 (0.70) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL19543950 | 0.84 | SSTR2 (0.61) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL21090931 | 0.83 | SSTR5 (0.78) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL8262030 | 0.83 | SSTR5 (0.78) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL18712336 | 0.83 | SSTR5 (0.78) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL18712350 | 0.83 | SSTR5 (0.78) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL21099493 | 0.83 | SSTR5 (0.77) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL22758987 | 0.80 | SSTR5 (0.73) | SSTR2SSTR5SSTR4SSTR3 | |
| SCHEMBL18712893 | 0.80 | SSTR2 (0.70) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL26814255 | 0.80 | SSTR2 (0.54) | SSTR2SSTR5SSTR4SSTR3SSTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11191778-B2 | Multifunctional linker technology containing an N4 group | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2021-12-07 | — | — | US | disclosed |
| US-20200085862-A1 | MULTIFUNCTIONAL LINKER TECHNOLOGY CONTAINING AN N4 GROUP | NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR | 2020-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11191778-B2 | Multifunctional linker technology containing an N4 group | NCL, CCNB1, CCNE1 | SSTR2 564/4885SSTR5 531/4885SSTR4 227/4885 |
| US-20200085862-A1 | MULTIFUNCTIONAL LINKER TECHNOLOGY CONTAINING AN N4 GROUP | NCL, CCNB1, CCNE1 | SSTR2 564/4885SSTR5 531/4885SSTR4 227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.